Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Chemistry and Laboratory Medicine
|
December 16, 2025
Serial measurements of neuron specific enolase, glial fibrillary acidic protein and neurofilament light for mortality prediction in patients with severe acute brain injury in the ICU
Wolmet E Haksteen, Lynn Boonkamp, Lisa Vermunt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 26, 2024
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design
Rebecca Z Rousset, Anouk den Braber, Inge M W Verberk, et al.
Alzheimer'S Research & Therapy
|
July 15, 2022
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
Kirsten E J Wesenhagen, Betty M Tijms, Lynn Boonkamp, et al.
Experimental Neurology
|
January 22, 2025
Cellular expression of low-density lipoprotein receptor-related protein 1 and amyloid beta deposition in human and rat epileptogenic brain
Annemieke Rozeboom, Diede W M Broekaart, Jasper J Anink, et al.
Annals of Clinical and Translational Neurology
|
October 24, 2018
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
Marta Del Campo, Daniela Galimberti, Naura Elias, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Calvin Trieu, Ellen Dicks, Mardou S S A van Leeuwenstijn, et al.
Journal of Alzheimer'S Disease : JAD
|
September 19, 2022
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
Katharina Bolsewig, Yanaika S Hok-A-Hin, Federica N Sepe, et al.
Alzheimer'S Research & Therapy
|
February 12, 2026
Development and validation of a novel panel of CSF biomarkers for Alzheimer's disease
Yanaika S Hok-A-Hin, Bram Bongers, Katharina Bolsewig, et al.
Neurology
|
September 25, 2020
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
Jozef Hanes, Andrej Kovac, Hlin Kvartsberg, et al.
JAMA Network Open
|
December 3, 2025
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline
Calvin Trieu, Argonde C van Harten, Mardou S S A van Leeuwenstijn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Chemistry and Laboratory Medicine
|
December 16, 2025
Serial measurements of neuron specific enolase, glial fibrillary acidic protein and neurofilament light for mortality prediction in patients with severe acute brain injury in the ICU
Wolmet E Haksteen, Lynn Boonkamp, Lisa Vermunt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 26, 2024
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design
Rebecca Z Rousset, Anouk den Braber, Inge M W Verberk, et al.
Alzheimer'S Research & Therapy
|
July 15, 2022
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
Kirsten E J Wesenhagen, Betty M Tijms, Lynn Boonkamp, et al.
Experimental Neurology
|
January 22, 2025
Cellular expression of low-density lipoprotein receptor-related protein 1 and amyloid beta deposition in human and rat epileptogenic brain
Annemieke Rozeboom, Diede W M Broekaart, Jasper J Anink, et al.
Annals of Clinical and Translational Neurology
|
October 24, 2018
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
Marta Del Campo, Daniela Galimberti, Naura Elias, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Calvin Trieu, Ellen Dicks, Mardou S S A van Leeuwenstijn, et al.
Journal of Alzheimer'S Disease : JAD
|
September 19, 2022
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
Katharina Bolsewig, Yanaika S Hok-A-Hin, Federica N Sepe, et al.
Alzheimer'S Research & Therapy
|
February 12, 2026
Development and validation of a novel panel of CSF biomarkers for Alzheimer's disease
Yanaika S Hok-A-Hin, Bram Bongers, Katharina Bolsewig, et al.
Neurology
|
September 25, 2020
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
Jozef Hanes, Andrej Kovac, Hlin Kvartsberg, et al.
JAMA Network Open
|
December 3, 2025
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline
Calvin Trieu, Argonde C van Harten, Mardou S S A van Leeuwenstijn, et al.
Page
of 2